Gian Luca Rampioni Vinciguerra

Pubblicazioni

Titolo Pubblicato in Anno
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulation JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2025
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice NPJ BREAST CANCER 2024
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma SIGNAL TRANSDUCTION AND TARGETED THERAPY 2024
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer EMBO MOLECULAR MEDICINE 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors JOURNAL OF PATHOLOGY 2024
Editorial: catch me if you can: cellular plasticity in tumor progression and drug resistance FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity SCIENCE ADVANCES 2024
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance SIGNAL TRANSDUCTION AND TARGETED THERAPY 2023
Clear cell carcinoma of the stomach: a rare tumor variant imparting poor prognosis ACTA CHIRURGICA BELGICA 2023
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation CANCER COMMUNICATIONS 2023
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysis CELL DEATH AND DIFFERENTIATION 2023
Role of Fra-2 in cancer CELL DEATH AND DIFFERENTIATION 2023
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review FRONTIERS IN ONCOLOGY 2022
EMILIN-1 deficiency promotes chronic inflammatory disease through TGFβ signaling alteration and impairment of the gC1q/α4β1 integrin interaction MATRIX BIOLOGY 2022
Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer CANCER RESEARCH 2022
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer JOURNAL OF PATHOLOGY 2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC EMBO MOLECULAR MEDICINE 2021
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer CELL DEATH & DISEASE 2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients. Results from the Phase IV MITO16A/ManGO OV-2 Translational Study CANCERS 2021
Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer CANCER RESEARCH 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma